Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127078831 | 12707883 | 1 | I | 20160727 | 20160823 | 20160901 | 20160901 | EXP | FR-PFIZER INC-2016399427 | PFIZER | 78.00 | YR | M | Y | 0.00000 | 20160901 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127078831 | 12707883 | 1 | PS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | Y | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 127078831 | 12707883 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 2.5 MG, 1X/DAY | Y | 19901 | 2.5 | MG | QD | ||||||
| 127078831 | 12707883 | 3 | SS | EXJADE | DEFERASIROX | 1 | Oral | 500 MG, 2X/DAY | Y | 0 | 500 | MG | DISPERSIBLE TABLET | BID | |||||
| 127078831 | 12707883 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | Y | 0 | 40 | MG | QD | ||||||
| 127078831 | 12707883 | 5 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 7 | C | CARDENSIEL | BISOPROLOL FUMARATE | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 9 | C | BUDESONIDE W/FORMOTEROL | BUDESONIDEFORMOTEROL | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 10 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 12 | C | THERALENE | TRIMEPRAZINE | 1 | 0 | ||||||||||||
| 127078831 | 12707883 | 13 | C | JAKAFI | RUXOLITINIB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127078831 | 12707883 | 1 | Cardiovascular event prophylaxis |
| 127078831 | 12707883 | 2 | Cardiovascular event prophylaxis |
| 127078831 | 12707883 | 3 | Polycythaemia vera |
| 127078831 | 12707883 | 4 | Congestive cardiomyopathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127078831 | 12707883 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127078831 | 12707883 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127078831 | 12707883 | 1 | 20160729 | 0 | ||
| 127078831 | 12707883 | 2 | 20160729 | 0 | ||
| 127078831 | 12707883 | 3 | 201607 | 20160729 | 0 | |
| 127078831 | 12707883 | 4 | 20160729 | 0 |